$DCTH
Delcath Systems Inc

2019 Q1 Form 10-Q Financial Statement

#000156459019025153 Filed on July 17, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1
Revenue $270.0K $700.0K
YoY Change -61.43% -5.79%
Cost Of Revenue $96.00K $147.0K
YoY Change -34.69% -32.88%
Gross Profit $174.0K $555.0K
YoY Change -68.65% 5.92%
Gross Profit Margin 64.44% 79.29%
Selling, General & Admin $2.549M $2.366M
YoY Change 7.73% -2.03%
% of Gross Profit 1464.94% 426.31%
Research & Development $3.300M $5.692M
YoY Change -42.02% 145.24%
% of Gross Profit 1896.55% 1025.59%
Depreciation & Amortization $65.00K $120.0K
YoY Change -45.83% 62.16%
% of Gross Profit 37.36% 21.62%
Operating Expenses $2.549M $8.058M
YoY Change -68.37% 70.14%
Operating Profit -$2.375M -$7.503M
YoY Change -68.35% 78.13%
Interest Expense -$2.229M -$2.000K
YoY Change 111350.0% -99.98%
% of Operating Profit
Other Income/Expense, Net $2.000K -$5.000K
YoY Change -140.0% -162.5%
Pretax Income -$7.890M $7.190M
YoY Change -209.74% -163.46%
Income Tax
% Of Pretax Income
Net Earnings -$7.894M $7.185M
YoY Change -209.87% -163.4%
Net Earnings / Revenue -2923.7% 1026.43%
Basic Earnings Per Share -$75.11 $10.91
Diluted Earnings Per Share -$0.11 $10.91
COMMON SHARES
Basic Shares Outstanding 73.56M 658.9K
Diluted Shares Outstanding 105.1K 658.9K

Balance Sheet

Concept 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $260.0K $2.030M
YoY Change -87.19% -68.28%
Cash & Equivalents $1.326M $3.116M
Short-Term Investments
Other Short-Term Assets $2.060M $1.610M
YoY Change 27.95% -92.78%
Inventory $780.0K $1.280M
Prepaid Expenses
Receivables $60.00K $280.0K
Other Receivables $0.00 $30.00K
Total Short-Term Assets $3.166M $5.230M
YoY Change -39.46% -82.55%
LONG-TERM ASSETS
Property, Plant & Equipment $3.000M $1.190M
YoY Change 152.1% 11.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.994M $1.190M
YoY Change 151.6% 11.21%
TOTAL ASSETS
Total Short-Term Assets $3.166M $5.230M
Total Long-Term Assets $2.994M $1.190M
Total Assets $6.160M $6.420M
YoY Change -4.05% -79.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.27M $4.580M
YoY Change 124.24% 554.29%
Accrued Expenses $9.380M $1.920M
YoY Change 388.54% 14.29%
Deferred Revenue
YoY Change
Short-Term Debt $5.390M $0.00
YoY Change
Long-Term Debt Due $370.0K
YoY Change
Total Short-Term Liabilities $25.44M $12.28M
YoY Change 107.25% -60.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $166.0K $345.0K
YoY Change -51.88% -36.7%
Total Long-Term Liabilities $166.0K $345.0K
YoY Change -51.88% -36.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.44M $12.28M
Total Long-Term Liabilities $166.0K $345.0K
Total Liabilities $29.94M $12.62M
YoY Change 137.25% -60.09%
SHAREHOLDERS EQUITY
Retained Earnings -$351.9M -$317.6M
YoY Change 10.8% 9.34%
Common Stock $144.0K $9.000K
YoY Change 1500.0% -99.24%
Preferred Stock
YoY Change
Treasury Stock (at cost) $51.00K
YoY Change 0.0%
Treasury Stock Shares $1.00
Shareholders Equity -$23.78M -$6.205M
YoY Change
Total Liabilities & Shareholders Equity $6.160M $6.418M
YoY Change -4.02% -79.32%

Cashflow Statement

Concept 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income -$7.894M $7.185M
YoY Change -209.87% -163.4%
Depreciation, Depletion And Amortization $65.00K $120.0K
YoY Change -45.83% 62.16%
Cash From Operating Activities -$2.770M -$6.443M
YoY Change -57.01% 68.66%
INVESTING ACTIVITIES
Capital Expenditures $2.000K $6.000K
YoY Change -66.67% -89.66%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.000K -$6.000K
YoY Change -66.67% -90.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 550.0K 4.253M
YoY Change -87.07% -30.16%
NET CHANGE
Cash From Operating Activities -2.770M -6.443M
Cash From Investing Activities -2.000K -6.000K
Cash From Financing Activities 550.0K 4.253M
Net Change In Cash -2.252M -2.208M
YoY Change 1.99% -199.91%
FREE CASH FLOW
Cash From Operating Activities -$2.770M -$6.443M
Capital Expenditures $2.000K $6.000K
Free Cash Flow -$2.772M -$6.449M
YoY Change -57.02% 66.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
New York
CY2019Q1 dei Entity Shell Company
EntityShellCompany
false
CY2019Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019Q1 us-gaap Assets Current
AssetsCurrent
3166000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2137000
CY2019Q1 us-gaap Notes Payable Current
NotesPayableCurrent
5390000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1024000
CY2018Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
33000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17750000
CY2018Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3405000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1117000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
166000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
628000
CY2019Q1 us-gaap Liabilities
Liabilities
29941000
CY2018Q4 us-gaap Liabilities
Liabilities
21783000
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
144000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
103000
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
327969000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
328962000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-351947000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-344054000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3116000
CY2019Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7000
CY2018Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-14697000
CY2019Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2229000
CY2018Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-7893000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
7187000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
57000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-120000
CY2018Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-34000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7836000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7153000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
10.91
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
10.91
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73558713
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
658893
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73558713
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
658893
CY2018Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
1:500
CY2018Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.002
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
54000
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
4000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
678000
CY2018Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
14000
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4252000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
18306000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-34000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-6202000
CY2019Q1 dcth Stock Option Compensation Income Expense
StockOptionCompensationIncomeExpense
54000
CY2018Q1 dcth Stock Option Compensation Income Expense
StockOptionCompensationIncomeExpense
7000
CY2019Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
4000
CY2018Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
14000
CY2019Q1 us-gaap Depreciation
Depreciation
65000
CY2018Q1 us-gaap Depreciation
Depreciation
120000
CY2019Q1 dcth Interest Income Earned On Money Market And Operating Accounts
InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts
0
CY2018Q1 dcth Interest Income Earned On Money Market And Operating Accounts
InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts
4000
CY2019Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
51000
CY2018Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
0
CY2019Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2160000
CY2018Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
108000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-152000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-523000
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-61000
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-24000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2902000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
828000
CY2019Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-462000
CY2018Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-50000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2770000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6443000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6000
CY2019Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
400000
CY2018Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0
CY2019Q1 dcth Proceeds From Sale Of Common Stock And Warrants
ProceedsFromSaleOfCommonStockAndWarrants
0
CY2018Q1 dcth Proceeds From Sale Of Common Stock And Warrants
ProceedsFromSaleOfCommonStockAndWarrants
4253000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
550000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4253000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-30000
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-12000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2252000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2208000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3578000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5324000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1326000
CY2019Q1 dcth Non Cash Activities Fair Value Of Warrants Issued
NonCashActivitiesFairValueOfWarrantsIssued
0
CY2018Q1 dcth Non Cash Activities Fair Value Of Warrants Issued
NonCashActivitiesFairValueOfWarrantsIssued
18306000
CY2019Q1 dcth Letters Of Credit Restricted Cash
LettersOfCreditRestrictedCash
1012000
CY2018Q4 dcth Letters Of Credit Restricted Cash
LettersOfCreditRestrictedCash
1012000
CY2019Q1 dcth Security For Credit Cards Restricted Cash
SecurityForCreditCardsRestrictedCash
50000
CY2018Q4 dcth Security For Credit Cards Restricted Cash
SecurityForCreditCardsRestrictedCash
50000
CY2019Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
341000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
358000
CY2019Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
434000
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
500000
CY2019Q1 dcth Income Tax And Value Added Tax Receivable Current
IncomeTaxAndValueAddedTaxReceivableCurrent
566000
CY2018Q4 dcth Income Tax And Value Added Tax Receivable Current
IncomeTaxAndValueAddedTaxReceivableCurrent
579000
CY2019Q1 us-gaap Prepaid Insurance
PrepaidInsurance
192000
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
140000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1785000
CY2019Q1 us-gaap Security Deposit
SecurityDeposit
50000
CY2018Q4 us-gaap Security Deposit
SecurityDeposit
51000
CY2019Q1 dcth Financing Costs Current
FinancingCostsCurrent
64000
CY2019Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
131000
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
128000
CY2019Q1 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2018Q4 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5226000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5232000
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4365000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4307000
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3122000
CY2019Q1 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
4151000
CY2018Q4 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
4530000
CY2019Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1087000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1649000
CY2019Q1 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2018Q4 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2019Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
298000
CY2019Q1 dcth Financing Lease Cost
FinancingLeaseCost
8000
CY2019Q1 us-gaap Sublease Income
SubleaseIncome
154000
CY2019Q1 us-gaap Lease Cost
LeaseCost
152000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
318000
CY2019Q1 us-gaap Proceeds From Lease Payments
ProceedsFromLeasePayments
154000
CY2019Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
12000
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
874000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
878000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1161000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
321000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2360000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
219000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2141000
CY2019Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
6100000
CY2019Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
300000
CY2019Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
5800000
CY2018Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
4500000
CY2018Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2500000
CY2018Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2000000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1250000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
83333
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1166667
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
112498
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.28
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.28
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.28
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.28
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y29D
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y5M4D
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
65685269
CY2019Q1 dcth Class Of Warrant Or Right Exercises In Period
ClassOfWarrantOrRightExercisesInPeriod
4119500
CY2019Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
61565769
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.22
CY2019Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.23
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
7000
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
26000
CY2018Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-14697000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7893000
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7510000
CY2018Q4 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
0.22
CY2019Q1 dcth Class Of Warrant Or Right Weighted Average Exercise Price Exercises In Period
ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod
0.01
CY2019Q1 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
0.23
CY2018 dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P5Y9M
CY2019Q1 dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P5Y5M26D
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
33000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5827163
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1014041
CY2018Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
2100000

Files In Submission

Name View Source Status
0001564590-19-025153-index-headers.html Edgar Link pending
0001564590-19-025153-index.html Edgar Link pending
0001564590-19-025153.txt Edgar Link pending
0001564590-19-025153-xbrl.zip Edgar Link pending
dcth-10q_20190331.htm Edgar Link pending
dcth-20190331.xml Edgar Link completed
dcth-20190331.xsd Edgar Link pending
dcth-20190331_cal.xml Edgar Link unprocessable
dcth-20190331_def.xml Edgar Link unprocessable
dcth-20190331_lab.xml Edgar Link unprocessable
dcth-20190331_pre.xml Edgar Link unprocessable
dcth-ex311_6.htm Edgar Link pending
dcth-ex312_8.htm Edgar Link pending
dcth-ex321_7.htm Edgar Link pending
dcth-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending